Intratumoral thrombosis as a histological biomarker for predicting epidermal growth factor receptor alteration and poor prognosis in patients with glioblastomas-Reference-Cited by-同舟云学术

Intratumoral thrombosis as a histological biomarker for predicting epidermal growth factor receptor alteration and poor prognosis in patients with glioblastomas

Published:2023-09 Issue:3 Volume:164 Page:633-641
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Furuta Takuya^ORCID,Negoto Tetsuya^ORCID,Miyoshi Hiroaki,Moritsubo Mayuko^ORCID,Nakamura Hideo,Morioka Motohiro,Akiba Jun^ORCID,Ohshima Koichi^ORCID,Sugita Yasuo^ORCID

Funder

Grant-in-Aids for Scientific Research from the Japanese Ministry of Education, Science, Sports, Technology and Culture

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11060-023-04447-8.pdf

Reference28 articles.

1. Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231–1251. https://doi.org/10.1093/neuonc/noab106

2. Rong Y, Durden DL, Van Meir EG, Brat DJ (2006) Pseudopalisading’ necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis. J Neuropathol Exp Neurol 65:529–539. https://doi.org/10.1097/00005072-200606000-00001

3. Perry JR (2012) Thromboembolic disease in patients with high-grade glioma. Neuro Oncol 14:73–80. https://doi.org/10.1093/neuonc/nos197

4. Markwell SM, Ross JL, Olson CL, Brat DJ (2022) Necrotic reshaping of the glioma microenvironment drives disease progression. Acta Neuropathol 143:291–310. https://doi.org/10.1007/s00401-021-02401-4

5. Eskilsson E, Rosland GV, Talasila KM, Knappskog S, Keunen O, Sottoriva A, Foerster S, Solecki G, Taxt T, Jirik R, Fritah S, Harter PN, Valk K, Al Hossain J, Joseph JV, Jahedi R, Saed HS, Piccirillo SG, Spiteri I, Leiss L, Euskirchen P, Graziani G, Daubon T, Lund-Johansen M, Enger PO, Winkler F, Ritter CA, Niclou SP, Watts C, Bjerkvig R, Miletic H (2016) EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through src activation. Neuro Oncol 18:1644–1655. https://doi.org/10.1093/neuonc/now113

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An MRI Radiomics Approach to Predict the Hypercoagulable Status of Gliomas;Cancers;2024-03-26

2. Whole Exome Sequencing in Vaccine‐Induced Thrombotic Thrombocytopenia (VITT);BioMed Research International;2024-01